{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T14:51:29Z","timestamp":1758120689167},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1994,1,1]],"date-time":"1994-01-01T00:00:00Z","timestamp":757382400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Digest Dis Sci"],"published-print":{"date-parts":[[1994,1]]},"DOI":"10.1007\/bf02090077","type":"journal-article","created":{"date-parts":[[2005,8,15]],"date-time":"2005-08-15T02:04:26Z","timestamp":1124071466000},"page":"161-168","source":"Crossref","is-referenced-by-count":29,"title":["Variability in individual response to various doses of omeprazole"],"prefix":"10.1007","volume":"39","author":[{"given":"Vincenzo","family":"Savarino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppi","family":"Sandro Mela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrizia","family":"Zentilin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrizia","family":"Cutela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Raffaella Mele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Vigneri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guido","family":"Celle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02090077_CR1","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0016-5085(90)91015-X","volume":"99","author":"DW Burget","year":"1990","unstructured":"Burget DW, Chiverton SG, Hunt RH: Is there an optimal degree of acid suppression for healing of duodenal ulcers? A model of the relationship between ulcer healing and acid suppression. Gastroenterology 99:345\u2013351, 1990","journal-title":"Gastroenterology"},{"key":"BF02090077_CR2","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1056\/NEJM198403223101211","volume":"310","author":"G Sachs","year":"1984","unstructured":"Sachs G: Pump blockers and ulcer disease. N Engl J Med 310:785\u2013786, 1984","journal-title":"N Engl J Med"},{"key":"BF02090077_CR3","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1056\/NEJM199104043241406","volume":"324","author":"PN Maton","year":"1991","unstructured":"Maton PN: Omeprazole. N Engl J Med 324:965\u2013975, 1991","journal-title":"N Engl J Med"},{"key":"BF02090077_CR4","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/bmj.290.6468.601","volume":"290","author":"PJ Prichard","year":"1985","unstructured":"Prichard PJ, Rubinstein D, Jones DB, Dudley FJ, Smallwood RA, Louis WJ, Yeomans ND: Double-blind comparative study of omeprazole 10 mg and 30 mg daily for healing duodenal ulcers. BMJ 290:601\u2013603, 1985","journal-title":"BMJ"},{"key":"BF02090077_CR5","unstructured":"Hui WM, Lam SK, Lau WY, Branicki FJ, Lai CL, Lok AS, Ng MMT, Poon KP, Fok PS: Omeprazole (OME) v ranitidine (RAN) for duodenal ulcer\u2014weekly endoscopic assessment. Gut 28:A1340, 1987 (abstract)"},{"key":"BF02090077_CR6","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1136\/gut.25.9.957","volume":"25","author":"BK Sharma","year":"1984","unstructured":"Sharma BK, Walt RP, Pounder RE, De Fa Gomes M, Wood EC, Logan LH: Optimal dose of oral omeprazole for maximal 24 hour decrease of intragastric acidity. Gut 25:957\u2013964, 1984","journal-title":"Gut"},{"key":"BF02090077_CR7","first-page":"191","volume":"32","author":"HG Dammann","year":"1985","unstructured":"Dammann HG, Walter ThA, M\u00fcller P, Simon B: Intragastric acidity under 28-day omeprazole treatment. Hepatogastroenterol 32:191\u2013194, 1985","journal-title":"Hepatogastroenterol"},{"key":"BF02090077_CR8","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0016-5085(85)80133-5","volume":"88","author":"PJ Prichard","year":"1985","unstructured":"Prichard PJ, Yeomans ND, Mihaly GW, Jones DB, Buckle PJ, Smallwood RA, Louis WJ: Omeprazole: A study of its inhibition of gastric pH and oral pharmacokinetics after morning and evening dosage. Gastroenterology 88:64\u201369, 1985","journal-title":"Gastroenterology"},{"key":"BF02090077_CR9","first-page":"148","volume":"11","author":"P Hemery","year":"1987","unstructured":"Hemery P, Galmiche JP, Roze C, Isal JP, Bruley des Varennes S, Lavignolle A, Le Bodic L: Low dose omeprazole effects on gastric acid secretion in normal man. Gastroenterol Clin Biol 11:148\u2013153, 1987","journal-title":"Gastroenterol Clin Biol"},{"key":"BF02090077_CR10","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3109\/00365528708991848","volume":"22","author":"J Naesdal","year":"1987","unstructured":"Naesdal J, Bankel M, Bodemar G, Gotthard R, Lundquist G, Walan A: The effect of 20 mg omeprazole daily on serum gastrin, 24-h intragastric acidity, and bile acid concentration in duodenal ulcer patients. Scand J Gastroenterol 22:5\u201312, 1987","journal-title":"Scand J Gastroenterol"},{"key":"BF02090077_CR11","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1007\/BF01535781","volume":"33","author":"V Savarino","year":"1988","unstructured":"Savarino V, Mela GS, Scalabrini P, Sumberaz A, Fera G, Celle G: 24-Hour study of intragastric acidity in duodenal ulcer patients and normal subjects using continuous intraluminal pH-metry. Dig Dis Sci 33:1077\u20131080, 1988","journal-title":"Dig Dis Sci"},{"key":"BF02090077_CR12","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1136\/gut.32.10.1104","volume":"32","author":"S Wagner","year":"1991","unstructured":"Wagner S, Gladziwa V, Gebel M, Sch\u00fcler A, Freise J, Schmidt FW: Circadian pattern of intragastric acidity in duodenal ulcer patients: A study of variation in relation to ulcer activity. Gut 32:1104\u20131109, 1991","journal-title":"Gut"},{"key":"BF02090077_CR13","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/j.1552-4604.1990.tb03437.x","volume":"30","author":"GS Mela","year":"1990","unstructured":"Mela GS, Savarino V: Inaccuracy of hourly sampled pH measurements in describing the effects of antisecretory drugs on circadian gastric acidity. J Clin Pharmacol 30:45\u201349, 1990","journal-title":"J Clin Pharmacol"},{"key":"BF02090077_CR14","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1136\/gut.24.4.270","volume":"24","author":"T Lind","year":"1983","unstructured":"Lind T, Cederberg C, Ekenved G, Haglund O, Olbe L: Effect of omeprazole\u2014a gastric proton pump inhibitor\u2014on pentagastrin stimulated acid secretion in man. Gut 24:270\u2013276, 1983","journal-title":"Gut"},{"key":"BF02090077_CR15","first-page":"826","volume":"10","author":"V Savarino","year":"1986","unstructured":"Savarino V, Mela GS, Scalabrini P, Magnolia MR, Di Timoteo E, Percario G, Celle G: Continuous intragastric pH monitoring: Focus on its reproducibility in duodenal ulcer patients. A preliminary report. Gastroenterol Clin Biol 10:826\u2013830, 1986","journal-title":"Gastroenterol Clin Biol"},{"key":"BF02090077_CR16","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3109\/00365528909093071","volume":"24","author":"V Savarino","year":"1989","unstructured":"Savarino V, Mela GS, Zentilin P, Magnolia MR, Scalabrini P, Valle F, Moretti M, Bonifacino G, Celle G: Gastric aspiration versus antimony and glass pH electrodes. A simultaneous comparative in vivo study. Scand J Gastroenterol 24:434\u2013439, 1989","journal-title":"Scand J Gastroenterol"},{"key":"BF02090077_CR17","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1007\/BF01540564","volume":"35","author":"GS Mela","year":"1990","unstructured":"Mela GS, Savarino V, Moretti M, Sumberaz A, Bonifacino G, Zentilin P, Caputo E, Villa G: Antimony and glass pH electrodes can be used interchangeably in 24-hour studies of gastric acidity. Dig Dis Sci 35:1473\u20131481, 1990","journal-title":"Dig Dis Sci"},{"key":"BF02090077_CR18","doi-asserted-by":"crossref","first-page":"683","DOI":"10.3109\/00365528909093109","volume":"24","author":"GS Mela","year":"1989","unstructured":"Mela GS, Savarino V, Moretti M, Bonifacino G, Sumberaz A, Zentilin P: Clinical relevance of sampling rate in the characterization and analysis of 24-hour gastric acidity. A report on 413 cases. Scand J Gastroenterol 24:683\u2013687, 1989","journal-title":"Scand J Gastroenterol"},{"key":"BF02090077_CR19","first-page":"1105","volume":"85","author":"GS Mela","year":"1990","unstructured":"Mela GS, Savarino V, Sumberaz A, Bonifacino G, Zentilin P, Villa G, Caputo E: Continuous acidity monitoring in the study of gastric antisecretory drugs: pH or antilog transformation of pH, mean or median? Am J Gastroenterol 85:1105\u20131108, 1990","journal-title":"Am J Gastroenterol"},{"key":"BF02090077_CR20","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/S0016-5085(16)34602-9","volume":"100","author":"GS Mela","year":"1991","unstructured":"Mela GS, Savarino V: Relationship between ulcer healing and acid suppression. Gastroenterology 100:1482\u20131483, 1991 (letter)","journal-title":"Gastroenterology"},{"key":"BF02090077_CR21","volume-title":"Statistical Methods for Rates and Proportions","author":"JL Fleiss","year":"1981","unstructured":"Fleiss JL: Statistical Methods for Rates and Proportions, 2nd ed. New York, John Wiley & Sons, 1981","edition":"2nd ed."},{"key":"BF02090077_CR22","first-page":"267","volume":"33","author":"CW Howden","year":"1986","unstructured":"Howden CW, Derodra JK, Burget DW, Hunt RH: Effects of low dose omeprazole on gastric secretion and plasma gastrin in patients with healed duodenal ulcer. Hepato-gastroenterol 33:267\u2013270, 1986","journal-title":"Hepato-gastroenterol"},{"key":"BF02090077_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000199818","volume":"42","author":"V Savarino","year":"1989","unstructured":"Savarino V, Mela GS, Zentilin P, Scalabrini P, Bonifacino G, Gambaro P, Celle G: Comparison of the effects of placebo, ranitidine, famotidine and nizatidine on intragastric acidity by means of continuous pH recording. Digestion 42:1\u20136, 1989","journal-title":"Digestion"},{"issue":"suppl 1","key":"BF02090077_CR24","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1159\/000200100","volume":"44","author":"HPM Festen","year":"1989","unstructured":"Festen HPM: Effect of omeprazole on gastric secretory functions. Digestion 44(suppl 1):18\u201324, 1989","journal-title":"Digestion"},{"key":"BF02090077_CR25","unstructured":"Bianchi Porro G, Bolling E, Barbara L, Blasi A, Capurso L, Corinaldesi R, Delle Fave G, Lazzaroni M, Mazzacca G, Paoluzi P, Torsoli A: Maintenance treatment with omeprazole in the prevention of duodenal ulcer relapse: A double-blind comparative trial. Gastroenterology 98:A21, 1990 (abstract)"},{"key":"BF02090077_CR26","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/0016-5085(91)80009-X","volume":"100","author":"K Lauritsen","year":"1991","unstructured":"Lauritsen K, Andersen BN, Laursen LS, Hansen J, Havelund T, Eriksen J, Rehfeld JF, Kjaergaard J, Rask-Madsen J: Omeprazole 20 mg three days a week and 10 mg daily in prevention of duodenal ulcer relapse. Double-blind comparative trial. Gastroenterology 100:663\u2013669, 1991","journal-title":"Gastroenterology"},{"key":"BF02090077_CR27","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1007\/BF01537099","volume":"34","author":"SK Lam","year":"1989","unstructured":"Lam SK, Hui WM, Ng MMT, Lok ASF, Lai LL, Branicki F, Lau WY, Poon GP: Reducing meal-stimulated acid secretion versus reducing nocturnal acid secretion for healing of duodenal ulcer. Dig Dis Sci 34:1494\u20131500, 1989","journal-title":"Dig Dis Sci"},{"key":"BF02090077_CR28","first-page":"85","volume":"2","author":"W Domschke","year":"1989","unstructured":"Domschke W, Lam SK, Pounder RE, Andersen D: H2-blocker-resistant duodenal ulceration. Gastroenterol Intern 2:85\u201391, 1989","journal-title":"Gastroenterol Intern"},{"key":"BF02090077_CR29","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1136\/bmj.301.6752.564","volume":"301","author":"GD Colin-Jones","year":"1990","unstructured":"Colin-Jones GD: Acid suppression: How much is needed? BMJ 301:564\u2013565, 1990","journal-title":"BMJ"},{"key":"BF02090077_CR30","first-page":"1329","volume":"301","author":"RE Pounder","year":"1990","unstructured":"Pounder RE, Prewett E: Acid suppression. BMJ 301:1329\u20131330, 1990 (letter)","journal-title":"BMJ"},{"key":"BF02090077_CR31","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1016\/0016-5085(90)91000-V","volume":"99","author":"V Savarino","year":"1990","unstructured":"Savarino V, Mela GS, Zentilin P, Celle G: Ulcer healing: does omeprazole efficacy depend on daytime or 24-hour acid inhibition? Gastroenterology 99:1858\u20131860, 1990 (letter)","journal-title":"Gastroenterology"},{"key":"BF02090077_CR32","doi-asserted-by":"crossref","first-page":"138","DOI":"10.2165\/00003495-199142010-00008","volume":"42","author":"D McTavish","year":"1991","unstructured":"McTavish D, Buckley M M-T, Heel RC: Omeprazole. An updated review of its pharmacology and therapeutic use in acid-related disorders. Drugs 42:138\u2013170, 1991","journal-title":"Drugs"},{"key":"BF02090077_CR33","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1365-2036.1987.tb00623.x","volume":"1","author":"S Lanzon-Miller","year":"1987","unstructured":"Lanzon-Miller S, Pounder RE, Hamilton MR, Ball S, Chronos NAF, Raymond F, Olausson M, Cederberg C: Twenty-four-hour intragastric acidity and plasma gastrin concentration before and during treatment with either ranitidine or omeprazole. Aliment Pharmacol Ther 1:239\u2013251, 1987","journal-title":"Aliment Pharmacol Ther"},{"key":"BF02090077_CR34","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/0016-5085(88)90003-0","volume":"94","author":"AP Archambault","year":"1988","unstructured":"Archambault AP, Pare P, Bailey RJ, Navert H, Williams CN, Freeman HJ, Baker SJ, Marcon NE, Hunt RH, Sutherland L, Kepkay DL, Saibil FG, Hawken K, Farley A, Levesque D, Ferguson J, Westin J-A: Omeprazole (20 mg daily) versus cimetidine (1200 mg daily) in duodenal ulcer healing and pain relief. Gastroenterology 94:1130\u20131134, 1988","journal-title":"Gastroenterology"},{"key":"BF02090077_CR35","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/BF01537225","volume":"35","author":"DY Graham","year":"1990","unstructured":"Graham DY, McCullough A, Sklar M, Sontag JJ, Roufail WM, Stone RC, Bishop RH, Gitlin N, Cagliola AJ, Berman RS, Humphries TJ: Omeprazole versus placebo in duodenal ulcer healing. The United States experience. Dig Dis Sci 35:66\u201372, 1990","journal-title":"Dig Dis Sci"},{"key":"BF02090077_CR36","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/BF01311234","volume":"36","author":"JE Valenzuela","year":"1991","unstructured":"Valenzuela JE, Berlin RG, Snape WJ, Johnsson TL, Hirschowitz BI, Colon-Pagan J, Morse RS, Petrozza J, Van Deventer GM, Cagliola A, Whipple J, Berman R, Humphries TJ, and the Omeprazole DU Comparative Study Group: US experience with omeprazole in duodenal ulcer. Multicenter double-blind comparative study with ranitidine. Dig Dis Sci 36:761\u2013768, 1991","journal-title":"Dig Dis Sci"},{"key":"BF02090077_CR37","first-page":"618","volume":"85","author":"V Savarino","year":"1990","unstructured":"Savarino V, Mela GS, Zentilin P, Celle G: Duodenal ulcer resistant to usual omeprazole dose. Am J Gastroenterol 85:618\u2013619, 1990 (letter)","journal-title":"Am J Gastroenterol"},{"key":"BF02090077_CR38","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1007\/BF01297469","volume":"36","author":"V Savarino","year":"1991","unstructured":"Savarino V, Mela GS, Vigneri S, Celle G: H2 antagonist and omeprazole nonresponders. Dig Dis Sci 36:1172\u20131173, 1991 (letter)","journal-title":"Dig Dis Sci"},{"key":"BF02090077_CR39","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1136\/gut.30.9.1173","volume":"30","author":"JC Delchier","year":"1989","unstructured":"Delchier JC, Isal JP, Eriksson S, Soule JC: Double-blind multicentre comparison of omeprazole 20 mg once daily versus ranitidine 150 mg twice daily in the treatment of cimetidine or ranitidine resistant duodenal ulcers. Gut 30:1173\u20131178, 1989","journal-title":"Gut"},{"key":"BF02090077_CR40","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1056\/NEJM198901123200201","volume":"320","author":"A Walan","year":"1989","unstructured":"Walan A, Bader J-P, Classen M, Lamers CBHW, Piper DW, Rutgersson K, Eriksson S: Effect of omeprazole and raitidine on ulcer healing and relapse rate in patients with benign gastric ulcer. N Engl J Med 320:69\u201375, 1989","journal-title":"N Engl J Med"},{"key":"BF02090077_CR41","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1159\/000199610","volume":"39","author":"G Brunner","year":"1988","unstructured":"Brunner G, Creutzfeldt W, Harke U, Lamberts R: Therapy with omeprazole in patients with peptic ulceration resistance to extended high-dose ranitidine treatment. Digestion 39:80\u201390, 1988","journal-title":"Digestion"},{"key":"BF02090077_CR42","first-page":"337","volume":"3","author":"G Delle Fave","year":"1991","unstructured":"Delle Fave G, Annibale B, Helander H, Puoti M, Corleto V, Franceschi M, Torsoli A: Omeprazole versus high dose ranitidine in H2 blocker resistant duodenal ulcer patients. Eur J Gastroenterol Hepatol 3:337\u2013342, 1991","journal-title":"Eur J Gastroenterol Hepatol"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02090077.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02090077\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02090077","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T10:05:44Z","timestamp":1557828344000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02090077"}},"subtitle":["Implications for antiulcer therapy"],"short-title":[],"issued":{"date-parts":[[1994,1]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1994,1]]}},"alternative-id":["BF02090077"],"URL":"https:\/\/doi.org\/10.1007\/bf02090077","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[1994,1]]}}}